MedPath

REThink resilience game - a pilot study to strengthen resilience in adolescents with chronic illness

Not Applicable
Conditions
Resilience
Z73
Problems related to life-management difficulty
Registration Number
DRKS00027870
Lead Sponsor
Klinik für Allgemeine Pädiatrie, Neonatologie und Kinderkardiologie, Universitätsklinikum Düsseldorf
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
All
Target Recruitment
47
Inclusion Criteria

Age: 12-16 years
- Chronic illness (defined as one or more of the following conditions: Illness > 1 year, mandatory long-term medical care, significant impairment of daily routine).
- Sufficient knowledge of German or English to use the app
- Sufficient physical as well as mental general condition to participate in the study (Lansky score= 80).
- Possession of an internet-enabled smartphone (iOs or Android) and internet access.
- Signed consent forms are available

Exclusion Criteria

- Mental or physical limitation that prevents use of the app or participation in the coaching group
- psychiatric illness (especially psychosis, acute suicidality) of the child or regular or current psychiatric/psychological treatment of the child (treatment > 3 months and/or psychological/psychiatric contact in the last 3 months)
- Declaration of consent is not available
- Lack of technical requirements such as smartphone or lack of internet access
- Lack of German or English language skills to use the app

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Primary endpoint is to analyze the feasibility of using the gaming application REThink(aligned with David et al, European Child & Adolescent Psychiatry (2019) 28:111-122). The study is considered feasible if: <br>- 70% of adolescents meeting inclusion criteria can be recruited,<br>- 85% of subjects complete all levels of the REThink app,<br>- 70% of subjects in the REThink app + coaching treatment group participate in both group sessions.<br><br><br>
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath